Ann M. Cunningham's most recent trade in VistaGen Therapeutics Inc was a trade of 17,600 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | Ann M. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2025 | 17,600 | 17,600 | - | - | Non-Qualified Stock Option (right to buy) | |
| VistaGen Therapeutics Inc | Ann M. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) |